FLINT, Mich., Jan. 15, 2018 /PRNewswire/ — Diplomat Pharmacy, Inc. (NYSE: DPLO) is dispensing Exelixis’ limited-distribution treatment CABOMETYX® (cabozantinib), now with an expanded indication.
CABOMETYX was recently approved by the Food and Drug Administration as a first-line…
